The University of Mississippi Medical Center (UMMC) offers twelve-month postgraduate year one (PGY1) pharmacy practice and postgraduate year two (PGY2) critical care and PGY2 infectious disease residencies, all accredited by the American Society of Health-System Pharmacists (ASHP). All residencies run from July 1 through June 30 of the following year. Residents are full-time professional staff members in an academic curriculum of the Department of Pharmacy Services who report directly to their Residency Program Director (RPD) and the Director of Pharmacy Services. Upon successful completion of all program requirements, residents are awarded a residency certificate indicating they have achieved the competency areas, goals, and objectives of their respective residency program.
This manual will serve to guide the resident by providing a general overview of various aspects of the residencyprograms.
The PGY1 Residency centers on development of the knowledge, skills, attitudes, and abilities gained from an accredited professional pharmacy degree program. The residency program enhances general competencies in managing medication use systems and supports optimal medication therapy outcomes for patients with a broad range of disease states.
PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilitiesas defined in the educational competency areas, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.
In order to achieve the desired goals of the PGY1 Pharmacy Residency Program, learning experiences have been developed to facilitate achievement of the ASHP required competency areas, goals, and objectives.
OrientationAdult Medicine(1) Critical Care Experience#(1) Pediatric Experience#
(1) Infectious Diseases Experience#
# Choose from elective rotation options below
Elective Monthly Rotations
In addition to the requirements listed in "Requirements for Graduation," residents must also complete all projects and requirements as listed on the "Annual PGY-1 Residency Requirements" checklist.
Back to Top
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
In addition to ASHP purpose of PGY2 residency programs, the PGY2 Critical Care Pharmacy Residency Program at University of Mississippi Medical Center exists to achieve three main overarching goals.
In order to achieve the desired goals noted above, learning experiences have been designed to facilitate achievement of ASHP required competency areas, goals, and objectives. Names of preceptors for each rotation are provided in the preceptor roster and learning experience descriptions.
ASHP competency areas, goals and objectives are selected for the PGY2 Critical Care Residency Program to meet the program's purpose. Residents are required to familiarize themselves with objectives associated with each goal.Objectives are intended to be matched with specific activities outlined in each learning experience. Achievement of all objectives for a specified goal will signify achievement of the associated goal and achievement of all goals for a specified outcome will signify achievement of the associated competency area.
In addition to the requirements listed in "Requirements for Graduation," the PGY2 Critical Care resident must also complete the following activities/projects.
In addition to ASHP purpose of PGY2 residency programs, the PGY2 Infectious Diseases Pharmacy Residency Program at University of Mississippi Medical Center exists to achieve three main overarching goals.
*Any required rotations may be repeated as electives
ASHP competency areas, goals and objectives are selected for the PGY2 Infectious Diseases Residency Program to meet the program's purpose. Residents are required to familiarize themselves with objectives associated with each goal. Objectives are intended to be matched with specific activities outlined in each learning experience. Achievement of all objectives for a specified goal will signify achievement of the associated goal and achievement of all goals for a specified outcome will signify achievement of the associated competency area.
In addition to the requirements listed in "Requirements for Graduation", the PGY2 Infectious Diseases resident must also complete the following activities/projects.
The Residency Program Director (RPD) is responsible for the overall quality of each residency program. They coordinate resident and preceptor activities in order to assure an effective and well-organized learning experience. The RPD must meet certain requirements as set forth by ASHP. Qualifications of the RPD are found in the ASHP Accreditation Standards for each respective program.
Currently, the programs and program directors are as follows:
The Residency Oversight Committee (ROC) consists of the RPDs of each program and the Director of Pharmacy. This committee exists to govern over the policies and procedures of the residency programs at the University of Mississippi Medical Center, in order to ensure compliance with the ASHP Accreditation Standards of each program. It will also serve as the governing body over decisions regarding program structure, preceptor appointment, and any issues regarding resident progression or discipline. The ROC will also meet to discuss and approve the final rank list prior to submission.
Each RPD will appoint members from its preceptor body to serve as members of a residency advisory committee (RAC) and will serve as the chair of this committee. The RAC will meet several times each year (ideally quarterly) to discuss the respective residency program. This committee exists to make recommendations to the ROC committee regarding:
The RAC will also be involved in each Quarterly Evaluation of the residents and will make recommendations to be included in the development plan of each resident. Any serious issues regarding resident progression may be addressed by this committee. The RAC will be involved in the resident selection process; will assist in determining the list of interview candidates; and will assist in the development of the final rank list.
The ROC will appoint members from the preceptor body to serve as members of a preceptor development committee. This committee serves to:
The PGY1 RPD will select 1 or more preceptors to serve as coordinators of the residency program. These coordinators will assist the RPD with administrative tasks, applicant management and interviews, coordinating scheduling of some events and orientation, etc. They will also hold monthly meetings with the residents to ensure that tasks and requirements are being completed in a timely manner. They will report directly to the RPD any resident, preceptor, or site performance issues that arise.
Preceptors will be appointed and reappointed by the preceptor development subcommittee with approval from the ROC. Please see the preceptor development policy for more details.
Preceptors are responsible for:
Each pharmacy resident will choose a mentor by September 1. Mentors will be expected to:
The applicant should be highly motivated with a desire to receive advanced training to enhance knowledge, skills, attitudes, and abilities related to the provision of direct patient care and project and practice management.
All rules and regulations of ASHP and the National Matching Service will be strictly followed.
In the event that a UMMC Pharmacy Residency program does not match in Phase I of the National Pharmacy Match, the recruitment, review, and interview process will be as follows.
Candidate Review and Invitations for Interviews:
Ranking of Candidates and Submission of Ranks:
Please see separate PGY-2 ID Early Commitment Policy
Significant deficiencies noted during any learning experience should be addressed by the preceptor during resident feedback, midpoint, and final evaluations. If the behavior or deficiencies still exist at the final evaluation (may be sooner for longitudinal experiences), the preceptor should discuss with the RPD and denote the deficiencies with NI on their PharmAcademic evaluations.
In such cases, appropriate remedial action will be undertaken after discussion with the RPD, RAC, and ROC. If the RAC and ROC deem appropriate, a performance improvement plan (PIP) will begin. The plan will be written out and signed by the resident, RPD, and Director of Pharmacy and will include objectives, along with activities and due dates of the objectives. The plan should be as specific as possible to give clear expectations and a plan for follow-up. During this time, the resident will meet with the RPD or another designee/mentor on a routine basis (not to be less than every other week but may be more frequent).
If the resident does not successfully complete the remediation, the ROC will review the assessments and determine the next course of action, up to and including dismissal from the program. Any extra time required to complete remediation after the end of residency will be uncompensated.
In conjunction with the PIP and with the approval of HR, the resident will enter in the progressive disciplinary process at this time, as well.
In addition to each program's specific graduation requirements (available in the program specific sections above), residents will also be required to meet the following requirements.
The following definitions will be used for all programs to document resident performance on evaluations.
Needs Improvement (NI)
Satisfactory Progress (SP)
Feedback to the resident shall be provided by the preceptor during each rotation at least weekly. Real-time self-evaluation is expected and encouraged from the residents.
All evaluations will be completed in PharmAcademic within 7 days of the end of the learning experience. Periodically, an overdue evaluation report in PharmAcademic will be run. Those individuals will be notified of the delinquency and expected to complete the evaluation ASAP.
Clinical pharmacists serving as preceptors will be granted 1 hour of administrative time to complete summative evaluations. It is the responsibility of the pharmacist to arrange coverage in advance.
The preceptor will provide and review rotation-specific ASHP Goals and Objectives and associated learning activities with the resident at the beginning of each learning experience.
All evaluations that do not include the appropriate comments will be sent back by the RPD for edits.
Preceptors should elaborate in the comments section of each objective unless denoted as ACHR so the resident knows the quality of his or her performance. Specific examples should be included as to how the resident is working to meet the objective. Specific examples of what the resident needs to do in order to achieve a goal should also be included.
Self-evaluation and reflection is required of all residents. The resident should consider and make comments regarding actions taken, quality of performance, learning points, and improvements to make for each objective.
An evaluation of the preceptor's performance will be completed by the resident at the end of a monthly learning experience and at least quarterly for longitudinal experiences. The preceptors and RPD will both cosign this evaluation. These evaluations should include strengths of the preceptors and ways to make future experiences more valuable to residents.
An evaluation of the learning experience will be completed by the resident at the end of a monthly learning experience and at least quarterly for longitudinal experiences. The most valuable aspects of the learning experience as well as improvements should be documented.
Each quarter, an assessment will be conducted with the RAC that will review learning experience assessments and progress with projects, research, and residency requirements for the resident. The RPD will discuss the assessment with the resident and identify methods to enhance learning as well as to strengthen areas for improvement. The RPD and resident will then complete a written update to the resident's customized training plan that reflects the discussion and findings from the meeting.
The University of Mississippi Medical Center pharmacists will serve as preceptors for the residents on the majority of their rotations. Additionally, the University of Mississippi School of Pharmacy (UMSOP) faculty and occasionally nonpharmacists may serve in instructor and/or preceptor roles.
UMMC PGY-1 Pharmacy Preceptors: The following requirements are in place for UMMC pharmacists serving as residency preceptors in our PGY-1 program:
UMMC PGY2 Pharmacy Preceptors: PGY-2 preceptors will have completed a PGY-2 residency plus one year of relevant experience or will have practiced extensively in the area they preceptor and have at least 3 years of experience. Preceptors must be actively practicing in the area in which they serve as preceptors.
University of Mississippi School of Pharmacy (UMSOP) Faculty: UMSOP faculty members are utilized to provide preceptorship for certain specialty areas. These faculty members will be designated as preceptors and must meet all ASHP preceptor requirements, participate in preceptor development, and adhere to all UMMC policies and procedures.
Non-Pharmacist Preceptors: Occasionally, it may be appropriate to use non-pharmacists as primary preceptors to give the resident experience in areas where there is no pharmacist practitioner. These situations are expected to be rare and must meet the following criteria:
Preceptor Development: The ROC and Residency Preceptor Development Committee (RPDC) will conduct a preceptor development program to ensure the quality of all preceptors. All pharmacist preceptors will be required to participate in this process. Additionally, the RPD and RPDC will ensure that all preceptors are providing adequate orientation, instruction, and feedback to the residents.
Quality Improvement: The ROC and RPDC will spearhead a continuous quality improvement assessment for the residency programs with regard to preceptor development. This will ensure compliance with ASHP standards and serve to improve upon cited deficiencies within the program.
Newly Appointed Preceptors: The RPD of the program and RPDC will design a preceptor training program for each newly appointed preceptor. Elements of this program are outlined in the Preceptor Development Policy and will be evaluated with the checklist that can be found in Appendix 5:
Improve and maintain the quality of preceptors associated with the University of Mississippi Medical Center (UMMC) pharmacy residency programs in accordance with the American Society of Health-Systems Pharmacists (ASHP) standards.
Residency Oversight Committee (ROC)
Residency Preceptor Development Committee (RPDC)
The preceptor development program will consist of various educational programs, meetings with preceptors, and other activities deemed appropriate by the RPDs or RPDC as needed.
Residents will be provided with ASHP and UMMC resources for well-being and resilience during orientation:
Residents will choose a professional mentor by September 1. Mentors chosen by the residents will join torgether and assist with planning well-being and team-building activities.
Well-being and burnout will be assessed regularly:
The Crisis Management Team will consist of the PGY-1 RPD, all PGY-2 RPDs, and the director of pharmacy. Other team members will be brought in on an as needed basis. The team will convene in the event of serious illness/injury or death of a pharmacy resident, preceptor, or program director.
Responsibilities of the Crisis Management Team include: